Form 8-K - Current report:
SEC Accession No. 0001070081-20-000127
Filing Date
2020-08-05
Accepted
2020-08-05 16:06:11
Documents
16
Period of Report
2020-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k8520.htm   iXBRL 8-K 42026
2 PRESS RELEASE ptctq2earningsrelease8.htm EX-99.1 194573
8 ptctq2earningsrelease_image1.gif GRAPHIC 6607
  Complete submission text file 0001070081-20-000127.txt   406994

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20200805.xsd EX-101.SCH 4701
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20200805_cal.xml EX-101.CAL 640
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20200805_def.xml EX-101.DEF 1490
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptct-20200805_lab.xml EX-101.LAB 26468
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20200805_pre.xml EX-101.PRE 13685
9 EXTRACTED XBRL INSTANCE DOCUMENT a8k8520_htm.xml XML 4246
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 201077266
SIC: 2834 Pharmaceutical Preparations